<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01585662</url>
  </required_header>
  <id_info>
    <org_study_id>1111</org_study_id>
    <nct_id>NCT01585662</nct_id>
  </id_info>
  <brief_title>Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents</brief_title>
  <official_title>Random Comparing Study on Two Different EUS-guided Pseudocyst Drainage Methods--Modified Naso-pancreatic Tube Drainage and Stents Drainage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiaoyin Zhang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fourth Military Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      EUS-guided pseudocyst drainage has been used world widely. Now, most endoscopists tend to
      place several stents to drain the content of cyst into GI tract. In the investigators
      experience, a modified naso-pancreatic tube drainage was more safer, easier and cheaper than
      placement of stents. Moreover, none of pseudocysts(total 19) drained by this modified
      naso-pancreatic tube drainage method were found recurrent with a follow up period from 3
      months-34 months. So, the investigators designed this prospective random comparing study to
      confirm the result.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence rate of pancreatic pseudocyst</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The complication rate</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pancreatic Pseudocyst</condition>
  <arm_group>
    <arm_group_label>Naso-pancreatic tube</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients enrolled in this group will be treated with modified naso-pancreatic tube drainage method.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stents</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients enrolled this group will be treated by placing the stents (at least 2 stents) between gastric and pancreatic pseudocyst.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EUS-guided pancreatic pseudocyst drainage</intervention_name>
    <description>EUS-guided pancreatic pseudocyst drainage by one 8 French naso-pancreatic tube or 2-3 two pig tails- stents.</description>
    <arm_group_label>Naso-pancreatic tube</arm_group_label>
    <arm_group_label>Stents</arm_group_label>
    <other_name>Naso-pancreatic drainage tube:8 Fren,made by Cook Company</other_name>
    <other_name>Two pig tails- stents:5cm long,made by Cook Company</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adults with ages from 18-80 years old.

          2. The pseudocysts were formed more than 3 months.

          3. The size of pseudocyst is more than 5 cm.

          4. The patient has the symptoms related with the pseudocyst.

          5. The distance between gastric and the wall of the pseudocyst is less than 1 cm from CT
             image.

          6. The consent form has been signed.

        Exclusion Criteria:

          1. The patient can't accept the endoscopic procedure.

          2. The patient has blood coagulation dysfunction.

          3. The patient has mental disorders.

          4. The patient has mild or severe cardiorespiratory insufficiency.

          5. The patient has hypertension and can't be controlled to safe level.

          6. Diabetics whose blood sugar level can't be controlled to safe level.

          7. Patients with alcohol dependence

          8. Pregnant and lactating women.

          9. The patients the investigator don't think suitable for this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wu Kaichun, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>The forth military medical university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaoyin Zhang, MD,PhD</last_name>
    <phone>86-29-84771540</phone>
    <email>zhangxy@fmmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xin Wang, MD,PhD</last_name>
    <phone>86-29-84771516</phone>
    <email>wangx@fmmu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xijing Institute of digestive diseases</name>
      <address>
        <city>Xian city</city>
        <state>Shanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoyin Zhang, MD,PhD</last_name>
      <phone>86-29-84771540</phone>
      <email>zhangxy@fmmu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Xin Wang, MD,PhD</last_name>
      <phone>86-29-84771516</phone>
      <email>wangx@fmmu.edu.cn</email>
    </contact_backup>
    <investigator>
      <last_name>Xiaoyin Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Baron TH, Wiersema MJ. EUS-guided transesophageal pancreatic pseudocyst drainage. Gastrointest Endosc. 2000 Oct;52(4):545-9.</citation>
    <PMID>11023579</PMID>
  </reference>
  <reference>
    <citation>Seewald S, Thonke F, Ang TL, Omar S, Seitz U, Groth S, Zhong Y, Yekebas E, Izbicki J, Soehendra N. One-step, simultaneous double-wire technique facilitates pancreatic pseudocyst and abscess drainage (with videos). Gastrointest Endosc. 2006 Nov;64(5):805-8.</citation>
    <PMID>17055880</PMID>
  </reference>
  <reference>
    <citation>Lopes CV, Pesenti C, Bories E, Caillol F, Giovannini M. Endoscopic-ultrasound-guided endoscopic transmural drainage of pancreatic pseudocysts and abscesses. Scand J Gastroenterol. 2007 Apr;42(4):524-9.</citation>
    <PMID>17454865</PMID>
  </reference>
  <reference>
    <citation>Barthet M, Lamblin G, Gasmi M, Vitton V, Desjeux A, Grimaud JC. Clinical usefulness of a treatment algorithm for pancreatic pseudocysts. Gastrointest Endosc. 2008 Feb;67(2):245-52. doi: 10.1016/j.gie.2007.06.014.</citation>
    <PMID>18226686</PMID>
  </reference>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2012</study_first_submitted>
  <study_first_submitted_qc>April 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2012</study_first_posted>
  <last_update_submitted>April 24, 2012</last_update_submitted>
  <last_update_submitted_qc>April 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fourth Military Medical University</investigator_affiliation>
    <investigator_full_name>Xiaoyin Zhang</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>EUS</keyword>
  <keyword>pancreatic pseudocyst</keyword>
  <keyword>drainage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Pseudocyst</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

